European pharmaceutical CEOs advocate for allowing drug prices to increase to U.S. levels to attract investment, citing that European price controls hinder market attractiveness. They urge the EU to set higher prices and incentivize innovation, as U.S. drug prices are significantly higher.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing